Cipla successfully opposed the grant of a patent to Boehringer for Tiotropium Bromide Monohydrate branded as Spiriva.This is utilized in inhalers.The patent was successfully opposed on the basis that it did not enhance therapeutic efficacy.
Law of the land as laid down by the Supreme Court of India
Comments
Post a Comment